These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6472516)

  • 1. Immunological monitoring of melanoma patients on BCG immunotherapy. I. Enzyme-linked immunosorbent assay of human sera after BCG-treatment.
    Kovatchev D; Kolushky V; Engibarov A
    Neoplasma; 1984; 31(4):453-8. PubMed ID: 6472516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B7 associated tuberculin hyporesponsiveness in BCG treated melanoma patients.
    Buckley CE; White DH; Seigler HF
    Monogr Allergy; 1977; 11():97-105. PubMed ID: 876133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
    Kokoschka EM; Micksche M
    Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological factors which influence response to immunotherapy in malignant melanoma.
    Morton D; Eilber FR; Malmgren RA; Wood WC
    Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.
    Zlotta A; Drowart A; van Vooren JP; Simon J; Schulman CC; Huygen K
    Acta Urol Belg; 1994 Sep; 62(3):63-8. PubMed ID: 7976857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological changes in cancer patients receiving BCG.
    Cochran AJ; Mackie RM; Jackson AM; Ogg LJ; Ross CE
    Dev Biol Stand; 1977 Apr 13-15; 38():441-8. PubMed ID: 608535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological significance of human melanoma cytotoxic antibody.
    Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
    Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer.
    Iwata T; Fujita T; Hirao N; Matsuzaki Y; Okada T; Mochimaru H; Susumu N; Matsumoto E; Sugano K; Yamashita N; Nozawa S; Kawakami Y
    Clin Cancer Res; 2005 May; 11(10):3949-57. PubMed ID: 15897597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay (ELISA) for antibodies to purified protein derivative of tuberculin (PPD). IgM-, IgA- and IgG- anti-PPD antibodies in active pulmonary tuberculosis.
    Viljanen MK; Eskola J; Tala E
    Eur J Respir Dis; 1982 May; 63(3):257-62. PubMed ID: 7095027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of intra-lesional injection of tuberculin-active protein on metastatic nodules of human malignant melanoma].
    Saida T
    Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1399-414. PubMed ID: 6984865
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basis for a specific-active immunotherapy in malignant melanoma].
    Mutzner PA; Stuhlmiller GM; Seigler HF; Stumpf WE; Sar M
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1322-5. PubMed ID: 7302537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial antibodies after tuberculin testing, BCG- vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay.
    Mauch H; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):380-8. PubMed ID: 6805156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of lymphocyte proliferation assay to purified protein derivative, enzyme linked immunosorbant assay, and tuberculin hypersensitivity in Eales' disease.
    Biswas J; Narain S; Roy S; Madhavan HN
    Indian J Ophthalmol; 1997 Jun; 45(2):93-7. PubMed ID: 9475026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
    Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
    Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma responses in peptide-treated melanoma patients measured by an ELISPOT assay using allogeneic dendritic cells.
    Gabrielsson S; Brichard V; Dhellin O; Dorval T; Bonnerot C
    Anticancer Res; 2004; 24(1):171-7. PubMed ID: 15015594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.